Antioxidant vitamins and cardiovascular disease

Proceedings of the Association of American Physicians

Volumn 111, Issue 1, 1999, Pages 2-9

  Gaziano, J M ^a  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Atherosclerosis; Coronary heart disease; Dietary supplements; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CORONARY RISK; FRUIT; HUMAN; OXIDATIVE STRESS; VEGETABLE;

EID: 0032930845     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.09229.x     Document Type: Conference Paper

References (55)

1. 1 Southorn P.A. & Powis G. Free radicals in medicine. II. Involvement in human disease. Mayo Clin. Proc. 63: 390 –408, 1988.
2. 2 Hessler J.R., Morel D.W., James L.J., Chisolm G.M. Lipoprotein oxidation and lipoprotein‐induced cytotoxicity. Arteriosclerosis 3: 215 222, 1983.
3. 3 Yagi K. Increased serum lipid peroxides initiate atherogenesis. Bioessays 1: 58 60, 1984.
4. 4 Quinn M.T., Parthasarathy S., Steinberg D. Endothelial cell‐derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc. Natl. Acad. Sci. USA 82: 5949 5953, 1985.
5. 5 Schaffner T., Taylor K., Bartucci E.J., et al. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am. J. Pathol. 100: 57 73, 1980.
6. 6 Gerrity R.G. The role of the monocyte in atherogenesis: I. Transition of blood‐borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103: 181 190, 1981.
7. 7 Fogelman A.M., Schechter I., Hokom M., et al. Malondialdehyde alteration of low density lipoproteins leads to cholesterol ester accumulation in human monocytemacrophages. Proc. Natl. Acad. Sci. USA 77: 2214 2218, 1980.
8. 8 Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76: 333 337, 1979.
9. 9 Salonen T., Yla‐Herttuala S., Yamamoto R., et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 339: 883 887, 1992.
10. 10 Acheson R.M. & Williams D.R.R. Does consumption of fruit and vegetables protect against stroke? Lancet 1: 1191 1193, 1983.
11. 11 Armstrong B.K., Mann J.L., Adelstein A.M., Eskin F. Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices. J. Chronic Dis. 36: 673 677, 1975.
12. 12 Verlangieri A.J., Kpaaeghian J.C., El‐Dean S., Bush M. Fruit and vegetable consumption and cardiovascular disease mortality. Med. Hypoth. 16: 7 15, 1985.
13. 13 Ginter E. Decline of coronary mortality in the United States and vitamin C. Am. J. Clin. Nutr. 32: 511 512, 1979.
14. 14 Gey K.F., Brubacher G.B., Stahelin H.B. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am. J. Clin. Nutr. 45: 1368 1377, 1987.
15. 15 Gey K.F. & Puska P. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross‐cultural epidemiology. Ann. N Y Acad. Sci. 570: 254 –282, 1989.
16. 16 Gey K.F., Stahelin H.B., Puska P., Evans A. Relationship of plasma vitamin C to mortality from ischemic heart disease. Ann. N Y Acad. Sci. 498: 110 123, 1987.
17. 17 Riemersma R.A., Oliver M., Elton M.A., et al. Plasma antioxidants and coronary heart disease: Vitamins C and E and selenium. Eur. J. Clin. Nutr. 44: 143 150, 1990.
18. 18 Riemersma R.A., Wood D.A., Macintyre C.H.H., et al. Risk of angina pectoris and plasma concentrations of vitamins A, C, E, and carotene. Lancet 337: 1 5, 1991.
19. 19 Riemersma R.A., Wood D.A., Macintyre C.C.H., et al. Low plasma vitamin E and C increased risk of angina in Scottish men. Ann. N Y Acad. Sci. 570: 291 295, 1989.
20. 20 Ramirez J. & Flowers N.C. Leukocyte ascorbic acid and its relationship to coronary heart disease in man. Am. J. Clin. Nutr. 33: 2079 2087, 1980.
21. 21 Kardinaal A.F.M., Kok F.J., Ringstad J., et al. Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC study. Lancet 342: 1379 1384, 1993.
22. 22 Manson J.E., Stampfer M.J., Willet W.C., et al. A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Circulation 84 (Suppl. II): 1991.
23. 23 Stampfer M.J., Hennekens C.H., Manson J.E., et al. A prospective study of vitamin E consumption and risk of coronary disease in women. N. Engl. J. Med. 328: 1444 1449, 1993.
24. 24 Manson J.E., Stampfer M.J., Willett W.C., et al. A prospective study of vitamin C and incidence of coronary heart disease in women. Circulation 85: 865, 1992.
25. 25 Willett W.C., Sampson L., Stampfer M.J., et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am. J. Epidemiol. 122: 51 65, 1985.
26. 26 Salvini S., Hunter D.J., Sampson L., et al. Food‐based validation of a dietary questionnaire: The effects of week‐to‐week variation in food consumption. Int. J. Epidemiol. 18: 858 867, 1989.
27. 27 Rimm E.B., Stampfer M.J., Ascherio A., et al. Dietary intake and risk of coronary heart disease among men. N. Engl. J. Med. 328: 1450 1456, 1993.
28. 28 Enstrom J.E., Kanim L.E., Klein M.A. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 3: 194 202, 1992.
29. 29 Gaziano J.M., Manson J.E., Branch L.G., et al. Dietary beta carotene and decreased cardiovascular mortality in an elderly cohort. J. Am. Coll. Cardiol. 19: 377, 1992.
30. 30 Lpaaidus L., Anderson H., Bengtson C., Bosceus I. Dietary habits in relation to incidence of cardiovascular disease and death in women; a 12‐year follow‐up of participants in the study of women in Gothenberg. Sweden Am. J. Clin. Nutr. 44: 444 448, 1986.
31. 31 Gey K.F., Stahelin H.B., Eicholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Prospective Basel Study. Clin. Invest. 71: 3 6, 1993.
32. 32 Eichholzer M., Stahelin H.B., and Gey K.F. Inverse correlation between essential antioxidants in plasma and subsequent risk to develop cancer, ischemic heart disease and stroke, respectively: 12‐year follow‐up of the Prospective Basel Study. In: Emerit I. and Chance B., (eds). Free Radicals and Aging. Basel: Birkhauser Verlag, 1992. pp 398–410.
33. 33 Morris D.L., Kritchevsky S.B., Davis C.E. Serum carotenoids and coronary heart disease in the Lipid Research Clinics Coronary Primary Prevention Trial [abstract]. Circulation 87 (1): 2, 1993.
34. 34 Salonen J.T., Nyyssonen K., Parviainen Kantola M., et al. Low plasma beta carotene, vitamin E and selenium levels associated with accelerated carotid atherogenesis in hypercholesterolemic eastern Finnish men. Circulation 87 (1): 1, 1993.
35. 35 Street D.A., Comstock G.W., Salkeld R.M., et al. A population based case‐control study of serum antioxidants and myocardial infarction. Am. J. Epidemiol. 134: 719 720, 1991.
36. 36 Kok F.J., De Bruijn A.M., Vermeeren R., et al. Serum selenium, vitamin antioxidants and cardiovascular mortality: A 9 year follow‐up study in the Netherlands. Am. J. Clin. Nutr. 45: 462 468, 1987.
37. 37 Salonen J.T., Salonen R., Penttila I., et al. Serum fatty acids, paaolipoproteins, selenium and vitamin antioxidants and risk of death from coronary artery disease. Am. J. Cardiol. 56: 226 231, 1985.
38. 38 Hennekens C. and Buring J.E. Observational evidence. Ann. N Y Acad. Sci. 703: 18–24, 1993.
39. 39 Blot W.J., Li J.Y., Taylor P.R., et al. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease‐specific mortality in the general population. J. Natl. Cancer Inst. 85: 1483 1492, 1993.
40. 40 The Alpha‐Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330: 1029 1035, 1994.
41. 41 Rpaaola J.M., Virtamo J., Haukka J.K., et al. Effect of vitamin E and beta carotene on the incidence of angina pectoris: A randomized, double‐blind, controlled trial. JAMA 275: 693 698, 1996.
42. 42 Stampfer M.J., Hennekens C.H., Manson J.E., et al. A prospective study of vitamin E consumption and risk of coronary disease in women. N. Engl. J. Med. 328: 1444 –1449, 1993.
43. 43 Rimm E.B., Stampfer M.J., Ascherio A., et al. Dietary intake and risk of coronary heart disease among men. N. Engl. J. Med. 328: 1450 1456, 1993.
44. 44 Hennekens C.H., Buring J.E., Manson J.E., et al. Lack of effect of long term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med. 334: 1145 1149, 1996.
45. 45 Omenn G.S., Goodman G.E., Thornquist M.D., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334: 1150 1155, 1996.
46. 46 Greenberg E.R., Baron J.A., Karagas M.R., et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 275: 660 703, 1996.
47. 47 Livingston P.D. & Jones C. Treatment of intermittent claudication with vitamin E. Lancet 2: 602 604, 1958.
48. 48 Williams H.T.G., Fenna D., MacBeth R.A. Alpha tocopherol in the treatment of intermittent claudication. Surg. Gynecol. Obstet. 132: 662 666, 1971.
49. 49 Haeger K. Long‐time treatment of intermittent claudication with vitamin E. Am. J. Clin. Nutr. 27: 1179 1181, 1974.
50. 50 Anderson T.W. & Reid W. A double‐blind trial of vitamin E in the treatment of angina pectoris. Am. Heart J. 93: 444 –449, 1974.
51. 51 Gillian R.E., Mandell B., Warbasse J.R. Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am. Heart J. 93 (1): 444 –449, 1977.
52. 52 DeMaio S.J., King III S.B., Lembo N.J., et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J. Am. Coll. Nutr. 11: 131 138, 1992.
53. 53 Gaziano J.M., Manson J.E., Ridker P.M., et al. Beta carotene therpaay for chronic stable angina. Circulation 82 (1): III 202, 1990.
54. 54 Stephens N.G., Parsons A., Schofield P.M., et al. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347: 781 786, 1996.
55. 55 Hennekens C.H., Buring J.E., Peto R. Antioxidant vitamins—benefits not yet proven. N. Engl. J. Med. 330: 1080 1081, 1994.